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Abstract
Background: Mast cells (MCs) play pivotal roles in allergy and innate immunity and consist of heterogenous
subclasses. However, the molecular basis determining the different characteristics of these multiple MC
subclasses remains unclear.
Results: To approach this, we developed a method of RNA extraction/amplification for intact in vivo MCs pooled
from frozen tissue sections, which enabled us to obtain the global gene expression pattern of pooled MCs
belonging to the same subclass. MCs were isolated from the submucosa (sMCs) and mucosa (mMCs) of mouse
stomach sections, respectively, 15 cells were pooled, and their RNA was extracted, amplified and subjected to
microarray analysis. Known marker genes specific for mMCs and sMCs showed expected expression trends,
indicating accuracy of the analysis.
We identified 1,272 genes showing significantly different expression levels between sMCs and mMCs, and
classified them into clusters on the basis of similarity of their expression profiles compared with bone marrow-
derived MCs, which are the cultured MCs with so-called 'immature' properties. Among them, we found that
several key genes such as Notch4  had sMC-biased expression and Ptgr1  had mMC-biased expression.
Furthermore, there is a difference in the expression of several genes including extracellular matrix protein
components, adhesion molecules, and cytoskeletal proteins between the two MC subclasses, which may reflect
functional adaptation of each MC to the mucosal or submucosal environment in the stomach.
Conclusion: By using the method of RNA amplification from pooled intact MCs, we characterized the distinct
gene expression profiles of sMCs and mMCs in the mouse stomach. Our findings offer insight into possible
unidentified properties specific for each MC subclass.
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Background
Mast cells (MCs) are derived from hematopoietic stem
cells and play important roles in allergic responses, innate
immunity and defense against parasite infection. Unlike
other blood cells, MCs migrate into peripheral tissues as
immature progenitors and differentiate into mature mast
cells. One of the unique features of MCs is that they show
a variety of phenotypes depending on the different tissue
microenvironment of their maturation [1]. In MCs, vari-
ous MC-specific serine proteases are stored in the secre-
tory granules, and their gene and protein expressions are
dramatically altered when their cell environment is
altered. For example, Reynolds et al. have shown that at
least six distinct members of mouse MC-specific serine
proteases are expressed in different combinations in dif-
ferent mast cell populations [2]. In addition, recent stud-
ies have shown that mature MCs vary in terms of what
surface receptors and lipid mediators they express [3,4].
Because each mast cell population in vivo must play a spe-
cific role in the body, it is important to determine the
character of each population of MCs.
Comprehensive gene expression analysis is a powerful
approach to understand the characterization of various
MC subpopulations. To date, several studies on microar-
ray analysis of MCs have been conducted [5-7], but most
of them dealt with MCs cultured in vitro. Alternatively,
gene expression profiles of MCs isolated from skin and
lung have been analyzed [3,8-10]. However, the numbers
of MCs analyzed as one sample were relatively high and
they were exposed to physical forces, enzymes and the
anti-Kit antibody for purification, during which the origi-
nal properties of the MCs may have been affected.
In the gastrointestinal tract, there are MCs that are mainly
classified into two subclasses; mucosal MCs (mMCs) and
submucosal MCs (sMCs) on the basis of their location,
morphology (size and shape) and granule contents
[11,12]. mMCs are mainly found in the mucosa of the gas-
trointestinal system, having chondroitin sulfate-contain-
ing granules, which are stained with toluidine blue but
not safranin, and their activation occurs during parasite
infection [13], while sMCs are localized in the submucosa
of the gastrointestinal tract and their granules are rich in
heparin and stained with both toluidine blue and safranin
[1,11]. However, the molecular basis determining the dif-
ferences in biochemical properties of these two MC sub-
classes remains uncertain, partially due to the difficulty of
their isolation.
To overcome these problems, here we established a
method of RNA amplification from intact MCs isolated
from frozen tissue sections, which enables us to conven-
iently obtain the global gene expression pattern of MCs in
various tissues. To validate this method, we first deter-
mined the minimum cell number required to achieve
reproducible RNA amplification. We then compared the
gene expression profiles obtained from small numbers of
mMCs and sMCs in the mouse stomach, and found sev-
eral key genes to be specifically expressed in one subclass
of MCs, which may reflect some aspects of the distinct
properties between the two MC subclasses in the gastroin-
testinal tract.
Results and discussion
Development of an RNA amplification protocol to obtain 
gene expression profiles from a small amount of RNA
To gain insight into the functional differences between the
different subclasses of MCs, we employed three rounds of
the T7-based RNA amplification method. Based on the
preliminary experiments using peritoneal MCs and bone
marrow-derived MCs (BMMCs), we estimated that a sin-
gle MC yields 2 pg of RNA. Before we performed compar-
ative analysis of MCs from different tissues, we first
evaluated the accuracy and reproducibility of three rounds
of the T7-based RNA amplification method, starting with
the amount of RNA that can be obtained from a single
MC. To assess this, we first compared the microarray
results obtained from 5 μg of BMMC RNA prepared by the
standard protocol with those obtained from the same
RNA diluted 105- or 106-fold (30 pg, 10 pg and 2 pg) and
subjected to three rounds of T7-based amplification (Fig-
ure 1a–c). Although three rounds of amplification yielded
enough quantity of RNA for microarray analysis (>20 μg)
even in the case of 2 pg RNA, scatter plot analysis revealed
that the qualities of the obtained results were quite differ-
ent between the samples from 5 μg and 2 pg RNA. The
genes judged as 'Presence' in both 30 pg and 5 μg of RNA
were 8,149 genes, which corresponded to 72% of genes
judged as 'Presence' in the 5 μg of RNA (11,344 genes; Fig-
ure 1a), while only 4,116 genes were judged as 'Presence'
in both 2 pg and 5 μg of RNA, which corresponded to only
36% of genes judged as 'Presence' in the 5 μg RNA (Figure
1c). The decrease in the number of genes judged as 'Pres-
ence' in the diluted samples (30 pg, 10 pg and 2 pg) may
be due to the loss of low copy number RNA species during
amplification.
We next examined the reproducibility of the microarray
results obtained from two sets of 30 pg BMMC RNA sam-
ples (30 pg-1 and 30 pg-2) or two sets of 2 pg samples (2
pg-1 and 2 pg-2) (Figure 1d and 1e). In the 30 pg RNA
samples, 7,537 (30 pg-1) and 8,777 (30 pg-2) genes were
judged as 'Presence'. However, only 4,324 (2 pg-1) and
4,460 (2 pg-2) genes were judged as 'Presence' in each 2
pg RNA sample, again suggesting the loss of low copy
number RNAs during amplification from a small amount
of RNA. As to the reproducibility, 86% of the 'Presence'
genes in the 30 pg-1 and 74% of 'Presence' genes in the 30
pg-2 sample were judged as 'Presence' in both 30 pg RNABMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
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samples, while only 57% of 'Presence' genes in the 2 pg-1
and 55% of 'Presence' genes in the 2 pg-2 sample were
judged as 'Presence' in both 2 pg RNA samples. These
results suggested that the amplified products from the
RNA from a single MC (about 2 pg) by the current method
may include considerable amplification artifacts causing
problems in accuracy and reproducibility. On the other
hand, because of the higher reproducibility (>74%), we
concluded that amplification from 30 pg RNA collected
from 15 MCs would be suitable for the practical analysis
of tissue MCs. Based on these results, we set our goal in
this study to acquire gene expression profiles of MCs
Comparisons of three round-amplified products starting with very small quantities of RNA Figure 1
Comparisons of three round-amplified products starting with very small quantities of RNA. (a-c) Amplification 
biases in the products starting from a small quantity of RNA. Scatter plots of signal intensity obtained from 5 μg of BMMC RNA 
prepared by the standard protocol and from 30 pg (a), 10 pg (b) and 2 pg (c) of BMMC RNA prepared by three rounds of 
amplification are shown. (d, e) Reproducibility of the three-round amplification of a small quantity of RNA. Scatter plots of sig-
nal intensity between two independent products from 30 pg of BMMC RNA (BMMC 30 pg-1 and BMMC 30 pg-2) (d) or from 
2 pg of BMMC RNA (BMMC 2 pg-1 and BMMC 2 pg-2) (e), are shown. Red dots show probe sets judged as "Presence", and 
yellow dots represent probe sets judged as "Absence" in both arrays. Blue dots show probe sets judged as "Presence" only in 
either array. The correlation coefficients (r) are presented. The same, four-fold induction and suppression thresholds are indi-
cated as diagonal lines. Genes judged as "Presence" are placed in groups corresponding to pairwise overlaps shown in the 
accompanying Venn diagrams.BMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
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pooled from different regions. To minimize the influence
of cell-to-cell variations within the same class and poten-
tial amplification artifacts, we prepared three sets of 15
MCs for each region and compared genes with signifi-
cantly different expression between MCs from the differ-
ent regions (Figure 2b). We chose stomach as the source
organ, since we can isolate two kinds of MCs from the
mucosa (mMC) and the submucosa (sMC) regions of the
same sections, and mMCs and sMCs have been suspected
to be different in several MC properties such as protease
expression profile and sensitivity to safranin staining
[1,11].
Gene expression profiles of submucosal and mucosal MCs 
from the stomach
To visualize two kinds of MCs in the stomach without
causing RNA degradation, the sections were fixed with car-
noy's fixative and metachromatically stained with toluid-
ine blue for a few seconds. sMCs and mMCs were
microdissected using a patch pipette (Figure 2a and 2b).
We prepared three sets of 15 MCs for each region,
extracted their RNA and individually amplified them
(sMC1, sMC2, sMC3, and mMC1, mMC2, mMC3). To
improve the recovery of the extraction of as little as 30 pg
of RNA, we used 'poly G' as a carrier, which does not inter-
fere with the following RNA amplification or hybridiza-
tion of the amplified product to the array (data not
shown). To examine the effects of nonspecifically ampli-
fied artifact products, we performed the RNA extraction/
amplification procedure without adding microdissected
cells ("no cell") as a negative control (described in "Mate-
rials and methods"). The amplified RNAs of sMCs, mMCs
and the "no cell" control were separately hybridized to a
murine microarray. The signal values in the "no cell" sam-
ple were low in general and similar to the background lev-
els (Figure 2c). The scatter plots of the samples
independently prepared within the same group (e.g. sMC1
vs sMC2) showed a similar expression pattern; the average
correlation coefficient for all probe-sets was 0.945 ± 0.004
and 0.893 ± 0.019 in sMCs and mMCs, respectively (n =
3). In contrast, the average correlation coefficient between
sMCs and mMCs was 0.752 ± 0.034 (n = 3), which was
much lower than those within the same group, suggesting
that their gene expression patterns are different.
We further evaluated the accuracy and reproducibility of
our method by other comprehensive analyses (hierarchi-
cal clustering analysis and principal component analysis
[PCA]) using all probe sets. Microarray data obtained
from sMCs, mMCs, skin-derived MCs, peritoneal MCs,
BMMCs and non-MCs (macrophages and fibroblasts)
were applied to these analyses. We first checked whether
the amplification process in our method affects the global
expression profile due to non-linear amplification. The
results from the BMMC samples using RNA prepared by
the standard protocol (BMMC-std) or the amplification
method (BMMC-amp) were subjected to these analyses.
Both hierarchical clustering analysis and PCA revealed
that microarray data from BMMC-std and BMMC-amp
were clustered in the same group (Figure 3a and 3b), sug-
gesting that the global similarity in gene expression pro-
files is maintained during the amplification process. We
next examined the similarity of expression patterns in
three independent sMC or mMC samples. Upon cluster-
ing analysis and PCA, sMC1–3 and mMC1–3 were clustered
in the same group, respectively. PCA also showed that the
expression profiles of sMCs, mMCs and BMMCs are
mutually different (Figure 3b).
We then compared the stomach-derived MCs (sMCs and
mMCs) with skin-derived MCs, peritoneal MCs, BMMCs
and non-MCs (macrophages and fibroblasts) by cluster-
ing analysis. The tissue-derived MCs (stomach MCs and
skin MCs) were clustered separately from peritoneal MCs
and BMMCs. These results may reflect different properties
between tissue-derived MCs with firm adhesion to the
neighboring cells and floating MCs without a tight con-
tact. As to the similarity of MCs with fibroblasts and mac-
rophages, it is reasonable that fibroblasts are most distant
from MCs and macrophages are closer to MCs as a leuko-
cyte family.
Validation of microarray results by real time RT-PCR 
analysis
We next investigated whether the hybridization signals of
known marker genes specific for sMCs and mMCs showed
the expected expression trends [12,14]. The mMC-specific
genes, mast cell protease 1 (Mcpt1) and 2 (Mcpt2) showed
higher values in mMCs, while the sMC-specific marker
genes, mast cell protease 4 (Mcpt4) and chymase 2
(Cma2), showed higher signal values in sMCs (Table 1
and Figure 4a) [15-29]. On the other hand, MC-common
markers such as kit oncogene (Kit) and Fcε receptor
(Fcer1a) showed significant signal values with no bias
between mMCs and sMCs. To further evaluate the results,
we measured the expression levels of these marker genes
by real-time RT-PCR using RNA from the independently
isolated MCs (Figure 4b). Moreover, we randomly
selected three genes showing 'mMC-biased' expression
and another three genes showing 'sMC-biased' expression;
expression of these genes in MCs has not been reported
previously (Figure 4a). There were no significant differ-
ences in the expression levels of Kit and Fcer1a between
mMCs and sMCs. In contrast, the mMC-specific markers
Mcpt1 and Mcpt2 and the 'mMC-biased' genes, Anxa10,
Ctse, and Fos showed higher expression in mMCs, and the
sMC-specific markers Mcpt4  and  Cma2  and the 'sMC-
biased' genes, Cnn1, Ces3, and Cpe showed higher expres-
sion in sMCs. These results indicate that the microarrayBMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
Page 5 of 13
(page number not for citation purposes)
Gene expression profiles of sMCs and mMCs from stomach tissue Figure 2
Gene expression profiles of sMCs and mMCs from stomach tissue. (a) Isolation of toluidine blue-stained MCs in the 
submucosa (sMC; upper panels) and the mucosa (mMC; lower panels) of stomach sections. A sMC (arrow) and mMC (arrowhead) 
that was metachromatically stained with toluidine blue before microdissection (left panels) disappeared after microdissection 
with a patch pipette (right panels). Bars, 10 μm. (b) Outline of the experimental strategy. (c) Labeled and fragmented antisense 
RNAs of three individual sMC samples, three individual mMC samples and the 'no cell' samples were hybridized to a Murine 
Array. Scatter plots for 'no cell' (x axis) and sMC1 (y axis) (upper left), 'no cell' (x axis) and mMC1 (y axis) (lower left), sMC1 (x 
axis) and sMC2 (y axis) (upper center), mMC1 (x axis) and mMC2 (y axis) (lower center), sMC1 (x axis) and mMC1 (y axis) (upper 
right) are shown. The correlation coefficients (r) for comparison within sMC1–3, within mMC1–3 and between sMCs and mMCs 
are presented as means ± S.D. Red dots show probe sets judged as "Presence", and yellow dots represent probe sets judged as 
"Absence" in both arrays. Blue dots show probe sets judged as "Presence" only in either array. The same, two-fold induction 
and suppression thresholds are indicated as diagonal lines.BMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
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results are reliable and reflect the gene expression profiles
of intact sMCs and mMCs in the stomach.
Clustering analysis of the gene expression profiles and 
functional categorization between sMCs and mMCs
Of the ~12,000 genes represented on the oligonucleotide
array, we selected 1,272 genes whose expression levels
between sMC1–3 and mMC1–3 were significantly different
(p < 0.05, Limma's t test). The expression level of each
gene was normalized by its level in BMMCs, which are cul-
tured MCs with so-called 'immature' properties, and the
selected genes were classified into seven clusters using the
k-means clustering algorithm (CL1-7; Figure 5a and Addi-
tional file 1). We also classified the genes into functional
categories, and the representative genes are listed (Figure
5b). Among them, 666 genes (52.4%) showed sMC-
biased expression (CL1-3); in 78% (519 genes) of sMC-
rich genes, the expression levels were relatively low in
BMMCs and augmented in sMC (CL1&2). For example,
the expression level of Mcpt4  was relatively low in
BMMCs, and if the expression profile of BMMCs reflects
the immature properties of MC progenitors, Mcpt4 can be
concluded to be induced during the final maturation into
sMCs. Interestingly, the sMC marker genes Mcpt5  and
Mcpt6  were classified into CL2/3, suggesting that these
genes were expressed to some extent in 'immature'
BMMCs, but their expression was suppressed during mat-
uration into mMCs. On the other hand, 606 genes
(47.6%) showed mMC-biased expression (CL4-7); in
51% (334 genes) of mMC-rich genes, their expression lev-
els in BMMCs were low but were augmented in mMCs
(CL4&5). For example, expression of Mcpt1 was low in
'immature' BMMCs but was drastically induced during
maturation into mMCs.
Protein expression of Notch4 in sMCs and Ptgr1 in mMCs 
in stomach tissue
Among the genes showing differential expression (Figure
5b), we further focused on the expression of Notch4 in
sMCs and Ptgr1 in mMCs, both of which have never been
previously characterized in MCs. The Notch4 gene product
is a member of the Notch family, consisting of transmem-
brane receptors which are activated by cell surface ligands
on adjacent cells. Recent studies have suggested that
Notch signaling is involved in lymphocyte and mast cell
differentiation [30,31]. We first confirmed that Notch4
expression is significantly higher in the separately pooled
sMCs than mMCs by real-time RT-PCR (data not shown).
Global gene expression analysis of sMC1–3 and mMC1–3 Figure 3
Global gene expression analysis of sMC1–3 and mMC1–3. (a) Hierarchical clustering of global gene expression of various 
preparations of MCs and non-MCs. Three-round amplified products of sMC1–3, mMC1–3, skin MCs and BMMCs, and the stand-
ard products of BMMCs, peritoneal MCs, macrophages and fibroblasts were analyzed. (b) The principal component analysis 
(PCA) reveals different gene expression profiles of sMC1–3, mMC1–3, and two preparations of BMMCs. The blue dotted square 
indicates mMCs, the red dotted square indicates sMCs, and the black dotted square indicates BMMCs.BMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
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Validation of the differentially expressed genes between sMCs and mMCs Figure 4
Validation of the differentially expressed genes between sMCs and mMCs. (a) sMC-specific (Cma2, Mcpt4), mMC-
specific (Mcpt1, Mcpt2) and MC-common markers (Fcer1a and Kit) (left panel) and six randomly selected genes (Ces3, Cnn1, 
Cpe, Anxa10, Ctse and Fos) (right panel) are indicated in the representative scatter correlation graphs between sMC1 and mMC1. 
The same, two-fold induction and suppression thresholds are indicated as a yellow, blue and red line, respectively. (b) The 
expression levels of the genes in (a) were verified by real-time RT-PCR. The values represent the ratio of relative expression 
levels of mMCs to sMCs, and are shown as mean ± S.D. (n = 3). The specificity of the PCR product was confirmed by gel elec-
trophoresis and analysis of the melting temperature. The expression level of each gene was normalized to 28S ribosomal RNA.BMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
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We next investigated whether the Notch4 protein is exclu-
sively present in sMCs by immunostaining of stomach tis-
sue (Figure 6a). Notch4 signals were detected in the
nucleus-like structures of sMCs but not in those of mMCs.
Furthermore, Notch4 signals were also found in the skin
MCs, which were adjacently clustered with sMCs (Figure
3a). These results show that Notch4 is present in sMCs but
not in mMCs, and suggest that Notch4 participates in
sMC-specific transcription of Notch-target genes, which
may be required for some sMC functions. In hematopoi-
etic cells, it has been reported that constitutively active
Notch4 promotes the expansion of progenitor cells and
inhibits myeloid differentiation [32]. Since Notch ligands
have been shown to exist in connective tissues such as skin
dermis [33], it will be interesting to explore whether
Notch4 plays a role in the differentiation of sMCs and the
maintenance of sMC functions.
The  Ptgr1  product, 15-oxo-prostaglandin 13-reductase/
leukotriene (LT) B4 12-hydroxydehydrogenase is an essen-
tial enzyme for inactivation of eicosanoids such as pros-
taglandin E2 (PGE2) and LTB4 [34]. Although it has been
reported that the pathways of eicosanoid synthesis differ
among the different MC subclasses [1,4], our results sug-
gest that the inactivation system of eicosanoids also varies
among the MC subclasses. Ptgr1 expression was found to
be significantly higher in the separately pooled mMCs by
real-time RT-PCR (data not shown). We also examined
Ptgr1 expression in stomach sections by immunostaining.
Signals for the Ptgr1 protein were found in granule-like
structures of mMCs in the stomach mucosa but not in
sMCs (Figure 6b), suggesting that the Ptgr1 enzyme may
be released from mMCs upon degranulation. Since PGE2
plays critical roles in the maintenance of gut homeostasis
through mucosal protection and inhibition of acid secre-
tion, it is possible that when activated, mMCs negatively
regulate the cytoprotective actions of PGE2 through rapid
inactivation by Ptgr1.
Gene expression pattern of extracellular matrix 
components, adhesion molecules, and cytoskeletal 
proteins in sMCs and mMCs
MC phenotypes have been shown to depend on their
interactions with the surrounding extracellular matrices
(ECMs) and neighboring cells [1]. One of the most
remarkable findings in this study is the difference in gene
expression of ECM protein components, adhesion mole-
cules, and cytoskeletal proteins, which may reflect func-
tional adaptation of each type of MC to the mucosal or
submucosal environment in the stomach (Figure 5b).
mMCs express genes for mucosa-specific ECM proteins
such as Muc1  (Mucin) and Tff1  (Trefoil factor), while
sMCs express genes for conventional ECM proteins such
as Col4a (procollagen) and Lama2 (laminin). Moreover,
sMCs express genes for adhesion molecules such as Alcam
and Vcam1, and genes for ordinary cytoskeletal proteins
such as Acta2 (actin), while mMCs express desmosome-
component genes such as Dsc2 (desmocollin) and Dsg2
(desmoglein), and genes for keratin intermediate fila-
ments such as Krt8 and Krt19. Desmosomes were reported
to be present in the stomach epithelia [35], and it was
found that desmosome-like structures are detected in a
particular type of MC [36]. It is thus possible that mMCs
interact with adjacent epithelia through desmosomal
adhesion in the stomach. In contrast, sMCs appear to
interact with neighboring cells via adhesion molecules
such as VCAM-1, ALCAM and VE-cadherin (Vcam1,
Alcam1 and Cdh5). Since these adhesion molecules have
been shown to be involved in dynamic regulation of the
actin cytoskeleton [37,38], such molecule-mediated inter-
Table 1: Summary of genes examined by real-time PCR analysis.
Gene Symbol Gene Name RefSeq Transcript ID Reference
Kit kit oncogene NM_021099 15
Fcer1a Fc fragment of IgE, high affinity I, receptor for α polypeptide NM_010184 16
Mcpt1 mast cell protease 1 NM_008570 17, 18
Mcpt2 mast cell protease 2 NM_008571 19
Mcpt4 mast cell protease 4 NM_010779 2, 20
Cma2 chymase 2, mast cell (mast cell protease 10) NM_001024714 14*
Anxa10 annexin A10 NM_011922 21
Ctse cathepsin E NM_007799 22
Fos FBJ osteosarcoma oncogene NM_010234 23
Ptgr1 Prostaglandin reductase 1 (leukotriene B4 12-hydroxydehydrogenase) NM_025968 24 (porcine)
Cnn1 calponin 1 NM_009922 25
Ces3 carboxylesterase 3 NM_053200 26
Cpe carboxypeptidase E NM_013494 27 (bovine)
Notch4 Notch gene homolog 4 NM_010929 28
28S rRNA 28S ribosomal RNA NR_003279 29
*, The coding sequence presented in this paper is the N-terminus truncated-form of Cma2, while the RefSeq "NM_001024714" is the complete 
sequence of Cma2.BMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
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Clustering analysis of the gene expression profiles between sMCs and mMCs Figure 5
Clustering analysis of the gene expression profiles between sMCs and mMCs. (a) Representation of mRNA expres-
sion levels of sMC1–3 and mMC1–3 compared with BMMCs. The color of the bars represents the ratio of signal intensity 
between independent samples and BMMCs, according to the scale shown on the top right. Genes with significantly different 
expression between sMCs and mMCs (p < 0.05, Limma's t test) were selected (1,272 genes) and classified into 7 clusters using 
the k-means algorithm (CL1-7). (b) Functional categorization of representative genes from (a).BMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
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actions with submucosal cells may be critical to maintain
the functional and morphological properties of sMCs.
Indeed, it should be noted that most sMCs are variable in
shape, and are often stretched and winding as compared
with mMCs [1].
Conclusion
We established a method of RNA amplification from
pooled intact MCs isolated from frozen tissue sections,
which enables us to conveniently obtain the global gene
expression pattern of MCs from various tissues, organs,
and species including humans. By using this method, we
demonstrated for the first time the distinct gene expres-
sion profiles of submucosal and mucosal MCs in the
mouse stomach. Our findings offer insight into possible
unidentified properties specific for each MC subclass.
Methods
Materials
The following materials were obtained from the sources
indicated: HPLC purified T7-(dT)24  primer [5'-
GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGC
GG(T)24] from GE Healthcare UK Ltd. (Buckinghamshire,
England), RNase-free water, dNTP, SusperScript II,
Escherichia coli (E. coli) RNase H, E. coli DNA polymerase
I, E. coli DNA ligase, T4 DNA polymerase and random
hexamers from Invitrogen (San Diego, CA), RNase inhib-
itor, glycogen, and MEGAscript T7 kit from Ambion (Aus-
tin, TX). Balb/c mice were obtained from JapanClea
(Hamamatsu, Japan). This study was approved by the
Committee on Animal Research of Kyoto University Grad-
uate School of Pharmaceutical Sciences.
RNA amplification and oligonucleotide microarray
Mouse interleukin-3-dependent BMMCs were prepared as
described previously [39]. Total RNA of BMMCs was
extracted using RNeasy mini kit (Qiagen, Valencia, CA).
Five micrograms of total RNA from BMMCs were labeled
and prepared for hybridization according to the manufac-
turer's instructions (standard protocol). On the other
hand, 30 pg, 10 pg and 2 pg of BMMC total RNA were
amplified and labeled by our original three-round ampli-
fication method, which is described below.
First round
Total RNA was incubated with T7-(dT)24 primer and first-
strand cDNA was then synthesized by SuperScript II (Inv-
itrogen). Second-strand synthesis was carried out by add-
ing RNase H, DNA polymerase I and DNA ligase. The
antisense RNA was synthesized using MEGAscript T7 kit.
Second round
The antisense RNA product was annealed with random
hexamers, and cDNA was again synthesized by Super-
Immunohistochemical analysis of Notch4 and Ptgr1 in sMCs and mMCs in stomach tissue Figure 6
Immunohistochemical analysis of Notch4 and Ptgr1 in sMCs and mMCs in stomach tissue. (a) Stomach submu-
cosa (sMCs; left panels), stomach mucosa (mMCs; middle panels) and skin (skin MCs; right panels) sections were stained with an 
anti-Notch4 antibody (lower panels) and with toluidine blue (upper panels). sMCs stained with the anti-Notch4 antibody in the 
gastric submucosa and skin dermis are indicated by arrows. No staining was observed in mMCs (arrowheads) localized in the 
gastric mucosa. sMCs and mMCs were metachromatically stained with toluidine blue. (b) Stomach submucosa (sMCs; left pan-
els) and stomach mucosa (mMCs; right panels) sections were stained with an anti-Ptgr1 antibody (lower panels) and with toluid-
ine blue (upper panels). No staining with the anti-Ptgr1 antibody was found in the sMCs (arrow). Small signals were observed in 
the mMCs (arrowheads). sMCs and mMCs were metachromatically stained with toluidine blue. Bars, 25 μm (a, b).BMC Genomics 2009, 10:35 http://www.biomedcentral.com/1471-2164/10/35
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Script II. Then, the RNA-cDNA hybrid was digested with
RNase H and annealed with the T7-(dT)24 primer, and
then second-strand synthesis was carried out by adding
DNA polymerase I. The antisense RNA was again synthe-
sized using MEGAscript T7 kit. Quality and size distribu-
tion of the antisense RNA product were confirmed by an
RNA 6000 Nano LabChip on the Agilent Bioanalyzer
(Palo Alto, CA).
Third round
As in the case of the second round, the double-stranded
cDNA with a T7-promoter sequence was prepared from
the second-round RNA product. Biotin-labeled antisense
RNA was synthesized by RNA Transcript Labeling Kit
(Enzo, Farmingdale, NY).
These labeled RNAs were hybridized to GeneChip Murine
Expression oligonucleotide arrays (Affymetrix, Santa
Clara, CA). We used microarray suite 5.0 of Affymetrix
GeneChip Operating Software for quantification of the
GeneChip data and decision of "Presence" or "Absence"
of expression of each probe set using the values of 11
paired (perfect-matched and mismatched) probes.
Microdissection of MCs from tissue sections, RNA 
extraction, and microarray data analysis
Tissue sections 7 μm in thickness were prepared using a
Jung Frigocut 3000E cryostat (Leica, Nussloch, Germany),
and thaw-mounted onto poly-L-lysine-coated glass slides.
To visualize MCs, the sections were fixed with carnoy's fix-
ative, and immersed in toluidine blue using the following
protocol: carnoy's fixative for 1 min, RNase-free water for
10 sec, toluidine blue (0.5% in 0.12N hydrochloric acid)
for 5 sec, RNase-free water for 10 sec, 70% ethanol for 15
sec, and 100% ethanol for 15 sec three times; the sections
were then vacuumed for 10 min to dry. Each single MC
was microdissected from the sections using a patch
pipette, and 15 cells were collected with an LCM Cap
using the PixCell Ile Laser Capture Microdissection Sys-
tem (Arcturus, Mountain View, CA). As a negative control,
LCM Caps just put on tissue sections without MCs were
subjected to the same protocols (no cell). Fifteen micro-
dissected MCs were homogenized in denaturing buffer of
RNeasy mini kits. Twenty nanograms of poly G (Sigma,
Saint Louis, MO) was added to the lysate as a nucleic acid
carrier, and total RNA was extracted. Fifty picograms of
BMMC total RNA (BMMC-amp) and total RNAs extracted
from sMCs in the stomach submucosa, mMCs in the
stomach mucosa and skin MCs in the ear dermis were
amplified and labeled using the three-round amplifica-
tion method, and were hybridized to U74Av2 Murine
Genome Array (Affymetrix). On the other hand, total RNA
of BMMCs (BMMC-std) and peritoneal MC, which were
collected from mouse peritoneal cavities and purified by
density gradient centrifugation using metrizamide, were
labeled and hybridized by the standard protocol. Raw
microarray data of macrophages (E-MEXP-38/
298290452) and fibroblasts (E-GEOD-6697/
1629511747) using the standard protocol were obtained
from ArrayExpress, a public repository for transcriptomics
data. We used either microarray suite 5.0 of Affymetrix
GeneChip Operating Software or the robust multi-array
average (RMA) expression measure for log transformation
(log2) and normalization of the GeneChip data [40,41].
To determine the similarity in the data, hierarchical clus-
tering analysis and PCA using the R statistical environ-
ment http://www.r-project.org w e r e  p e r f o r m e d  a s  a
visualization technique. For comparison of the expression
profiles of sMCs with that of mMCs, we selected 1,272
genes identified as having significantly different expres-
sion levels by the Limma's t-test (p < 0.05, n = 3). Signal
values of sMCs and mMCs were normalized by the signal
values of BMMCs. Using the k-means clustering algo-
rithm, these genes were classified into seven clusters on
the basis of similarity of their expression profiles.
Real-time reverse-transcription polymerase chain reaction 
(RT-PCR)
Total RNA extracted from 60 captured MCs was subjected
to real-time RT-PCR. Real-time PCR was performed in a
LightCycler (Roche, Mannheim, Germany) using Fast
Start DNA Master SYBR Green I. The expression level of
each gene was quantified using external standardized
dilution, and normalized by 28S ribosomal RNA. Primer
sequences are shown in Table 2. The specificity of the
primers was confirmed by checking the product size and
restriction enzyme pattern by gel electrophoresis and the
melting temperature (data not shown).
Immunostaining
For tissue staining, frozen sections were fixed in 4% for-
maldehyde and incubated with a rabbit anti-Notch4 anti-
body (1:20, Santa Cruz Biotechnology, Santa Cruz, CA) or
a rabbit anti-Ptgr1 antibody (1:20) which was a kind gift
from Prof. Takao Shimizu (University of Tokyo) [42].
Abbreviations
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